Xiaflex Market Report 2026

Xiaflex Market Overview

• The Xiaflex market growth in the historic period has been driven by increasing prevalence of dupuytren’s contracture, rising awareness of non-surgical treatment alternatives • Market expansion is supported by increasing demand for outpatient biologic treatments, rising focus on reducing surgical interventions • Growth Driver: Impact Of Peyronie’s Disease On Market Growth • Market Trend: Advancements In Treatment Options For Peyronie's Disease • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Xiaflex Market?

Xiaflex (collagenase clostridium histolyticum) is a biologic injectable treatment used for the management of dupuytren's contracture and peyronie's disease. It works by enzymatically breaking down the collagen that causes tissue buildup and the contracture of affected tendons or plaques. It is administered via subcutaneous injection by a healthcare professional, and it is typically used in patients who are not candidates for surgery or for those seeking an alternative treatment option. The main types of indications in xiaflex include dupuytren’s contracture, peyronie’s disease, and others. Dupuytren’s contracture refers to a condition where the tissue beneath the skin of the palm thickens, forming nodules that cause the fingers to bend inward, and xiaflex is used to break down the collagen buildup, helping straighten the fingers and improve hand movement. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies for end users such as adults and geriatrics.

What Is The Xiaflex Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for outpatient biologic treatments, rising focus on reducing surgical interventions, expansion of personalized medicine approaches, growing geriatric population, continued innovation in collagen-targeting therapies. Major trends in the forecast period include increasing adoption of enzymatic non-surgical therapies, rising preference for minimally invasive treatment options, growing focus on targeted biologic injectables, expansion of physician-administered specialty therapies, enhanced emphasis on patient-specific treatment planning.

Global Xiaflex Market Segmentation

1) By Indication: Dupuytren’s Contracture, Peyronie’s Disease, Other Indications 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End User: Adult, Geriatric

What Is The Driver Of The Xiaflex Market?

The rising prevalence of peyronie’s disease is anticipated to fuel the growth of the xiaflex market going forward. Peyronie’s disease is a connective tissue disorder characterized by the development of fibrous plaques in the penis, causing curvature and discomfort. The rise in peyronie’s disease is driven by factors such as aging, genetics, and injury-related tissue damage. XIAFLEX is used in peyronie’s disease to break down the fibrous plaques, improving penile curvature and function. For instance, in February 2023, according to data published by The Urology Care Foundation, the US-based foundation of the American Urological Association, dedicated to advancing urological care through research, education, and community support, approximately 4 out of 100 men between the ages of 40 and 70 are affected by peyronie’s disease. Additional evidence suggests that around 0.5% of adult American males are diagnosed with peyronie’s disease. Therefore, the rising prevalence of peyronie’s disease is expected to drive the growth of the xiaflex industry.

Key Players In The Global Xiaflex Market

Major companies operating in the xiaflex market are Endo Inc.

Global Xiaflex Market Trends and Insights

The key trend in the xiaflex market is focusing on exploring alternative treatment protocols for resistant cases, such as targeted research for xiaflex use in surgery and expanding its therapeutic applications addressing unmet needs in hand and connective tissue disorders. Xiaflex is being explored for its potential benefits in surgical applications, particularly in reducing the need for invasive procedures and improving patient recovery. For instance, in May 2024, Endo International Plc, a US-based pharmaceutical company, announced the presentation of new data related to Peyronie's disease and XIAFLEX at the American Urological Association's (AUA) annual meeting. These studies, supported by Endo's investigator-initiated research grants, focused on comparing XIAFLEX to surgery as well as exploring new treatment protocols for patients who did not respond to prior therapies. The company's ongoing commitment to advancing XIAFLEX's clinical outcomes reflects its dedication to improving patient care and expanding its potential therapeutic applications.

What Are Latest Mergers And Acquisitions In The Xiaflex Market?

In April 2024, Endo Inc., a US-based specialty pharmaceutical company, acquired assets of Endo International plc for an undisclosed amount. This acquisition marks the formation of a new entity focused on growth with a diversified product portfolio, positioning Endo for sustained development and strategic growth. Endo International plc is a US-based generic and branded drug manufacturing company offering xiaflex.

Regional Insights

North America was the largest region in the xiaflex market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Xiaflex Market?

The xiaflex market consists of sales of single-use vials containing collagenase clostridium histolyticum for injectable use. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Xiaflex Market Report 2026?

The xiaflex market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the xiaflex industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.